FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1356-1358 April 29, 1999 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Furrer, H. PubMed Citation

Before the advent of antiretroviral therapy and prophylaxis against Pneumocystis carinii pneumonia, this type of pneumonia ultimately developed in 60 to 80 percent of adult patients with human immunodeficiency virus (HIV) infection in North America and Western Europe.¹ Seventy percent of patients had a second episode of P. carinii pneumonia within 12 months after the first episode.¹ The implementation of prophylaxis to prevent an initial episode of pneumonia (primary prophylaxis) or a subsequent episode (secondary prophylaxis) was the first intervention that substantially increased survival and improved the quality of life for patients with HIV infection. It was subsequently recognized that . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Roland, M. E., Lo, B., Braff, J., Stock, P. G. (2003). Key Clinical, Ethical, and Policy Issues in the Evaluation of the Safety and Effectiveness of Solid Organ Transplantation in HIV-Infected Patients. Arch Intern Med 163: 1773-1778 [Full Text]  
• Goldie, S. J., Kaplan, J. E., Losina, E., Weinstein, M. C., Paltiel, A. D., Seage III, G. R., Craven, D. E., Kimmel, A. D., Zhang, H., Cohen, C. J., Freedberg, K. A. (2002). Prophylaxis for Human Immunodeficiency Virus-Related Pneumocystis carinii Pneumonia: Using Simulation Modeling to Inform Clinical Guidelines. Arch Intern Med 162: 921-928 [Abstract] [Full Text]  
• de Quiros, J. C. L. B., Miro, J. M., Pena, J. M., Podzamczer, D., Alberdi, J. C., Martinez, E., Cosin, J., Claramonte, X., Gonzalez, J., Domingo, P., Casado, J. L., Ribera, E., The Grupo de Estudio del SIDA 04/98, (2001). A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis against Pneumocystis carinii Pneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection. NEJM 344: 159-167 [Abstract] [Full Text]  
• Mansharamani, N. G., Balachandran, D., Vernovsky, I., Garland, R., Koziel, H. (2000). Peripheral Blood CD4 + T-Lymphocyte Counts During Pneumocystis carinii Pneumonia in Immunocompromised Patients Without HIV Infection. Chest 118: 712-720 [Abstract] [Full Text]  
• Cohen, O. J. (2000). Antiretroviral Therapy: Time To Think Strategically. ANN INTERN MED 132: 320-322 [Full Text]  
• (1999). Stopping PCP Prophylaxis Appears Safe. AIDS Clin Care 1999: 3-3 [Full Text]  
• (1999). Stopping PCP Prophylaxis Appears Safe for Some HIV+ Patients. JWatch General 1999: 1-1 [Full Text]